Chargement en cours...
The role of checkpoints in the treatment of GBM
Targeted immunotherapy is founded on the principle that augmentation of effector T cell activity in the tumor microenvironment can translate to tumor regression. Targeted checkpoint inhibitors in the form of agonist or antagonist monoclonal antibodies have come to the fore as a promising strategy to...
Enregistré dans:
| Publié dans: | J Neurooncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750481/ https://ncbi.nlm.nih.gov/pubmed/25749875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1747-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|